BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28211349)

  • 1. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
    Zhang X; Zhao Y; Zheng Y; Dong Y
    J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
    Gammon D; Bhargava P; McCormick MJ
    Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
    Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
    J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
    [No Abstract]   [Full Text] [Related]  

  • 5. Desensitizing oxaliplatin-induced fever: a case report.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Guillen-Ponce C; Sanz ML; Alvarez-Cuesta E
    J Investig Allergol Clin Immunol; 2013; 23(6):435-6. PubMed ID: 24459821
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
    Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
    Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization.
    Rose PG; Metz C; Link N
    Int J Gynecol Cancer; 2014 Nov; 24(9):1603-6. PubMed ID: 25304679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
    Bhargava P; Gammon D; McCormick MJ
    Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.
    Tuttle KL; Stavrou E; Hong DIC; Connell NT; Wickner P
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):267-269. PubMed ID: 33971363
    [No Abstract]   [Full Text] [Related]  

  • 10. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful desensitization to oxaliplatin.
    Mis L; Fernando NH; Hurwitz HI; Morse MA
    Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.
    Lim KH; Huang MJ; Lin HC; Su YW; Chang YF; Lin J; Chang MC; Hsieh RK
    Anticancer Drugs; 2004 Jul; 15(6):605-7. PubMed ID: 15205605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
    Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
    Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
    Syrigou E; Syrigos K; Saif MW
    Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
    Nozawa H; Muto Y; Yamada Y
    Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P
    Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions.
    Shao YY; Hu FC; Liang JT; Chiu WT; Cheng AL; Yang CH
    J Formos Med Assoc; 2010 May; 109(5):362-8. PubMed ID: 20497869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.